TRAVERSING Wisely: Testosterone Replacement Therapy in Clinical Practice
Friday September 18, 12:15 – 12:45pm
Online Section 1 Webinar
Section 1 Webinar
September 18, 12:15-12:45pm
Learning Objectives
- Select an appropriate Testosterone Replacement Therapy (TRT) based on patient factors, safety considerations, and treatment goals. (CanMEDS: Medical Expert)
- Apply Choosing Wisely Canada recommendations to identify patients who are appropriate candidates for TRT. (CanMEDS: Medical Expert, Health Advocate)
- Integrate evidence from the TRAVERSE trial into risk-benefit discussions and shared decision-making regarding TRT cardiovascular safety.(CanMEDS: Scholar, Communicator)
Faculty
Dr. Ari Morgenthau
Moderator
Dr. Adam Millar
Speaker
The session is complimentary for CSEM members and $150 for non-members. If you would like to receive this education at the member rate, please login and renew.
This Group Learning activity (Section 1) was planned independently by CSEM to achieve scientific integrity, objectivity, and balance.
Sponsorship
This program has received an unrestricted educational grant from Tolmar and was planned independently by CSEM to achieve scientific integrity and balance.
Accreditation
TRAVERSING Wisely: Testosterone Replacement Therapy in Clinical Practice will be an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada, as approved by The Canadian Society of Endocrinology and Metabolism.
Registration
Dr. Adam Millar
Dr. Millar is an Associate Professor at the University of Toronto and a Clinician Teacher in the Division of Endocrinology and Metabolism at Mount Sinai Hospital in Toronto. He is a general endocrinologist with clinical expertise in andrology, and manages several andrologic conditions including male hypogonadism, infertility, sexual dysfunction, gynecomastia and differences of sexual development. He also has one of the largest Klinefelter Syndrome populations in Ontario. He is the Fellowship Director of the first Endocrine Andrology Program in Canada, based at the University of Toronto.
Dr. Millar has received several teaching awards, including The University Health Network/Mount Sinai Hospital Department of Medicine Excellence in Teaching Award, The University of Toronto MD Program Teaching Award for Excellence, The University of Toronto Division of Endocrinology George From Postgraduate Teaching Award, and The University of Toronto Division of Endocrinology Robert Volpe Undergraduate Teaching Award.
Disclosures:
Honoraria for Speaking, Participation in Advisory Boards – Dexcom, Novo Nordisk, Pendopharm, Sanofi, Tolmar
Participation and Moderation of Advisory Boards – Pendopharm, Tolmar
Ari Morgenthau BSc., MSc., MD, FRCPC
Dr. Ari Morgenthau is a Clinician-Teacher in the Division of Endocrinology and Metabolism, at the University of Toronto. Ari has a special interest in Endocrine Genetics and divides his clinical time between the Fred A. Litwin Family Centre in Genetic Medicine and the Toronto General Hospital General Endocrinology Clinic. Ari completed his MD at New York Medical College, his core Internal Medicine training at Dalhousie University, and his Adult Endocrinology and Metabolism training at the University of Toronto. Additionally, he completed a Clinical and Metabolic Genetics fellowship at the University of Toronto, has a Master of Science from the University of Calgary, and a Graduate Certificate in Genomic Counselling and Variant Interpretation from the University of British Columbia.
Conflict of Interest
Relationship – Global Genes, Non Financial Advisory Position related to the RARE Compassion Program.